On September 18, 2008, I wrote that Transmeta was a potential takeover target:
If you're looking for a growth story, this isn't it; however, as long as its patent portfolio remains viable, TMTA may be a potential takeover target or value play at the right price.
On November 18, 2008, Novafora acquired Transmeta:
This appears to be a good outcome for Transmeta. Kudos to the Board of Directors and to the officers for selling the company in a professional, transparent manner.